Abstract
Toll-like receptor 4 (TLR4) belongs to a large family of pattern recognition receptors that play a key role in innate immunity and inflammatory response. Increasing evidence has shown that TLR4 signaling pathway plays an essential role in mediating the immune response and central nervous system (CNS) repair and development. Brain inflammation and innate immunity has been implicated as a secondary injury mechanism following stroke, exacerbating neural damage to impede recovery. After stroke, a series of signaling pathways are triggered by dying cells or other factors in both the local innate immune cells in brain and other immune cells from bloodstream, contributing to the brain inflammatory response. In this review, we discuss the TLR4 signaling in association with recent findings concerning the involvement of TLR4 signaling pathway in stroke-induced inflammation and brain injury, and then study the key mechanisms associated with TLR4 signaling pathway in the above processes, suggesting the potential for therapeutic intervention by targeting TLR4 signaling pathway.
Keywords: TLR4 signaling pathway, NF-kB, ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, inflammation.
Current Signal Transduction Therapy
Title:Toll-Like Receptor 4 Signaling Pathway as a Potential Targets for Stroke-Induced Inflammation
Volume: 12 Issue: 1
Author(s): Jing Sun and Guangxian Nan*
Affiliation:
- Department of Neurology, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun 130000, Jilin,China
Keywords: TLR4 signaling pathway, NF-kB, ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, inflammation.
Abstract: Toll-like receptor 4 (TLR4) belongs to a large family of pattern recognition receptors that play a key role in innate immunity and inflammatory response. Increasing evidence has shown that TLR4 signaling pathway plays an essential role in mediating the immune response and central nervous system (CNS) repair and development. Brain inflammation and innate immunity has been implicated as a secondary injury mechanism following stroke, exacerbating neural damage to impede recovery. After stroke, a series of signaling pathways are triggered by dying cells or other factors in both the local innate immune cells in brain and other immune cells from bloodstream, contributing to the brain inflammatory response. In this review, we discuss the TLR4 signaling in association with recent findings concerning the involvement of TLR4 signaling pathway in stroke-induced inflammation and brain injury, and then study the key mechanisms associated with TLR4 signaling pathway in the above processes, suggesting the potential for therapeutic intervention by targeting TLR4 signaling pathway.
Export Options
About this article
Cite this article as:
Sun Jing and Nan Guangxian*, Toll-Like Receptor 4 Signaling Pathway as a Potential Targets for Stroke-Induced Inflammation, Current Signal Transduction Therapy 2017; 12 (1) . https://dx.doi.org/10.2174/1574362411666160926095724
DOI https://dx.doi.org/10.2174/1574362411666160926095724 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide
Current Medicinal Chemistry Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
CNS & Neurological Disorders - Drug Targets Recent Advances in Asthma Genetics and Antiasthma Therapy
Current Respiratory Medicine Reviews Human Microdialysis
Current Pharmaceutical Biotechnology Evaluation of Post-Surgical Cognitive Function and Protein Fingerprints in the Cerebro-Spinal Fluid Utilizing Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass-Spectrometry (SELDI-TOF MS) After Coronary Artery Bypass Grafting: Review of Proteomic Analytic Tools and Introducing a New Syndrome
Current Medicinal Chemistry The Pathophysiology of Sleep Apnoea: What We have Learned from Animal Models of Chronic Intermittent Hypoxia
Current Respiratory Medicine Reviews Estrogen, Neuroprotection and Neurogenesis after Ischemic Stroke
Current Drug Targets Calcium Ion – The Key Player in Cerebral Ischemia
Current Medicinal Chemistry Isosteviol Protects H9c2 Cells Against Hypoxia-reoxygenation by Activating ERK1/2
Cardiovascular & Hematological Disorders-Drug Targets Promotion of Insulin-Like Growth Factor-I Production by Sensory Neuron Stimulation; Molecular Mechanism(s) and Therapeutic Implications
Current Medicinal Chemistry Structure, Function and Interactions of Tau: Particular Focus on Potential Drug Targets for the Treatment of Tauopathies
CNS & Neurological Disorders - Drug Targets Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)
Current Pharmaceutical Design Medical Image Processing Technology for Diagnosing and Treating Cancers
Recent Patents on Biomedical Engineering (Discontinued) Molecular Links Between Endothelial Dysfunction and Neurodegeneration in Alzheimer's Disease
Current Alzheimer Research Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery
Current Pharmaceutical Design The Animal Models of Dementia and Alzheimer’s Disease for Pre-Clinical Testing and Clinical Translation
Current Alzheimer Research Effect of the NMDA-Receptor Antagonist Dextromethorphan in Infant Rat Pneumococcal Meningitis
Current Drug Metabolism G-Lymphatic, Vascular and Immune Pathways for Aβ Clearance Cascade and Therapeutic Targets For Alzheimer’s Disease
Combinatorial Chemistry & High Throughput Screening New Perspectives for the Diagnosis of Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Safety and Efficacy of Aliskiren in the Treatment of Hypertension and Associated Clinical Conditions
Current Drug Safety